NCT02828254View on ClinicalTrials.gov

A Follow-up Evaluation Study of PRI-724-1101

CompletedOBSERVATIONAL
Enrollment

8

Participants

Timeline

Start Date

December 18, 2014

Primary Completion Date

March 27, 2017

Study Completion Date

January 31, 2018

Conditions
Hepatitis C Virus-infected Cirrhosis
Interventions
DRUG

PRI-724

Trial Locations (1)

Unknown

Tokyo metropolitan Komagome Hospital, Tokyo

Sponsors
All Listed Sponsors
collaborator

Prism Pharma Co., Ltd.

INDUSTRY

collaborator

Japan Agency for Medical Research and Development

OTHER_GOV

lead

Komagome Hospital

OTHER